2005
DOI: 10.1111/j.1365-2036.2005.02468.x
|View full text |Cite
|
Sign up to set email alerts
|

Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non‐erosive gastro‐oesophageal reflux disease

Abstract: SUMMARYBackground: Several studies in Western countries showed that proton-pump inhibitors are superior to histamine 2 -receptor antagonists or placebo in the treatment of non-erosive gastro-oesophageal reflux disease. The efficacy of acid-suppressive drugs for nonerosive gastro-oesophageal reflux disease in Japan, in which the prevalence of Helicobacter pylori infection is higher compared with Western countries, is unknown. Aim: To compare the efficacy of famotidine and omeprazole in Japanese patients with no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
39
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(40 citation statements)
references
References 43 publications
(79 reference statements)
1
39
0
Order By: Relevance
“…This instrument is an abdominal symptom-related QOL scale similar to the GSRS (4, 10); it is composed of 5 symptom domains for determining various abdominal symptom-and domain-specific QOL impairments. GSRS has been widely used to measure abdominal symptom-specific QOL impairments and is reported to clearly show the QOL changes in response to treatment in Japanese patients with abdominal symptoms (11,12). However, in contrast to the GSRS and other general QOL scales, the Izumo scale was designed to detect QOL changes caused by abdominal symptoms frequently noted by Japanese patients (13)(14)(15).…”
Section: Discussionmentioning
confidence: 99%
“…This instrument is an abdominal symptom-related QOL scale similar to the GSRS (4, 10); it is composed of 5 symptom domains for determining various abdominal symptom-and domain-specific QOL impairments. GSRS has been widely used to measure abdominal symptom-specific QOL impairments and is reported to clearly show the QOL changes in response to treatment in Japanese patients with abdominal symptoms (11,12). However, in contrast to the GSRS and other general QOL scales, the Izumo scale was designed to detect QOL changes caused by abdominal symptoms frequently noted by Japanese patients (13)(14)(15).…”
Section: Discussionmentioning
confidence: 99%
“…Three studies using the Medical Outcomes Study Short Form-36 (SF-36) demonstrated that HR-QOL in GERD patients was lower than that in the general Japanese population. [66][67][68] A recent study by Hongo et al [69] using a new questionnaire (QOLRAD) which has been developed as a specific QOL assessment of GERD, showed impairment of HR-QOL in GERD patients.…”
Section: Prevalence and Clinical Characteristics Of Symptomatic Gerd mentioning
confidence: 99%
“…The prevalence of the symptoms respectively in males and females were: heartburn, 15.8% (sometimes 15.3%, usually 0.5%) vs 20.7% (sometimes 20.1%, usually 0.6%); dysphagia, 5.4% (sometimes 5.0%, usually 0.4%) vs 7.8% (sometimes 7.3%, usually 0.5%); and abdominal pain, 6.6% (sometimes 6.5%, usually 0.1%) vs 9.6% (sometimes 9.4%, usually 0.2%). Among these symptoms, heartburn was significantly high compared with the other symptoms, and all symptoms were significantly more common in females than in males.…”
Section: Frequency Of Respective Symptomsmentioning
confidence: 99%
“…Some studies have reported acid suppressive therapy resolves epigastric pain in patients with GERD [5,6] . According to these studies, epigastric pain might be one of the clinical symptoms of GERD.…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation